
Flight simulators are used to test pilots, we create a cell simulator to test treatments11-50 Employees
- Early StageStartup in initial stages
Cytocast careers
Cytocast revolutionizes drug discovery and personalized treatment by integrating bioinformatics databases with patient data into computer models to understand the effects of perturbations caused by diseases and predict how drugs can modify cellular health.
Problem 1
Drug development is costly, and most often fails in the last stage. An efficient method is needed to select the best drug candidates for clinical trials.
SOLUTION 1
Cytocast predicts positive and negative effects of treatments using computer simulations to reduce time and cost of drug development.
Problem 2
There is no competent way to tell which treatment is the best for a given individual.
SOLUTION 2
Applying our tool on personalized data selects the best treatment for each individual.
Our software utilizes various types of molecular information, called multi-omics data, collected from diseased and healthy cells.
The tool integrates personalized data with the existing knowledge on how molecules interact to perform their functions forming structures called macromolecular complexes, which ultimately perform the major functions in a cell. Looking at cellular behavior from a large-scale point of view, we can identify global variations between healthy cells and those affected by a disease, which are typically impossible to observe by looking at a single component of a cell.
Our simulation tool allows us to predict phenotypic effects of diseases and drugs with much better precision than alternative approaches, which rely on genomic data.
COMPETITIVE ADVANTAGE
Cytocast is the only tool which runs large-scale simulations to capture the whole complexity of biological systems. We incorporate multi-level data to reach more reliable predictions on cellular health. Furthermore, our simulations provide mechanistic insights not just statistical probabilities.
Problem 1
Drug development is costly, and most often fails in the last stage. An efficient method is needed to select the best drug candidates for clinical trials.
SOLUTION 1
Cytocast predicts positive and negative effects of treatments using computer simulations to reduce time and cost of drug development.
Problem 2
There is no competent way to tell which treatment is the best for a given individual.
SOLUTION 2
Applying our tool on personalized data selects the best treatment for each individual.
Our software utilizes various types of molecular information, called multi-omics data, collected from diseased and healthy cells.
The tool integrates personalized data with the existing knowledge on how molecules interact to perform their functions forming structures called macromolecular complexes, which ultimately perform the major functions in a cell. Looking at cellular behavior from a large-scale point of view, we can identify global variations between healthy cells and those affected by a disease, which are typically impossible to observe by looking at a single component of a cell.
Our simulation tool allows us to predict phenotypic effects of diseases and drugs with much better precision than alternative approaches, which rely on genomic data.
COMPETITIVE ADVANTAGE
Cytocast is the only tool which runs large-scale simulations to capture the whole complexity of biological systems. We incorporate multi-level data to reach more reliable predictions on cellular health. Furthermore, our simulations provide mechanistic insights not just statistical probabilities.
Cytocast hasn't added any jobs yet
Get notified when Cytocast posts new jobs.
Helga Reguly
Istvan Reguly
CIO at Cytocast
Bence Keömley-Horváth
Attila Csikász-Nagy
Computational modelling of biological systems in the academic life, predicting drug effects in the start-up world.
Simone Rizzetto
Whole cell simulation pioneer
CPO & co-founder of Cytocast ltd.
Valuation
$0
Funded over
1 round
Latest round
Pre-Seed (Dec 2021)
Exagen Diagnostics • Carlsbad • $130k – $160k • 1 week ago
Amgen • Thousand Oaks • $171k – $232k • 1 week ago
Pacific Biosciences • Menlo Park • $148k – $222k • 1 week ago
Glaxosmithkline • Seattle • $158k – $264k • 1 week ago
Agoda • Chicago • $172k – $202k • 2 weeks ago